查詢結果分析
相關文獻
- Eradication of Hepatitis C Virus Preserve Liver Function and Prolong Survival in Advanced Hepatocellular Carcinoma Patients with Limited Life Expectancy
- 人格同一與存活
- 臨床研究最重要的統計分析方法:存活分析(Survival analysis)
- Sorafenib (Nexavar®)--臺灣第一個晚期肝癌治療藥物
- Sorafenib (Nexavar®)--治療腎細胞癌又見新藥
- 荔枝露疫病菌之特性與生態研究
- Association between Body Mass Index and Clinical Outcomes in Out-of-hospital Cardiac Arrest Survivors Treated with Targeted Temperature Management、
- Association between Body Mass Index and Clinical Outcomes in Out-of-hospital Cardiac Arrest Survivors Treated with Targeted Temperature Management、
- Second Primary Oral Cancers after Curative Surgery
- Experience of Sorafenib Treatment in Differentiated Thyroid Cancer from Taiwan
頁籤選單縮合
題 名 | Eradication of Hepatitis C Virus Preserve Liver Function and Prolong Survival in Advanced Hepatocellular Carcinoma Patients with Limited Life Expectancy |
---|---|
作 者 | Yeh, Ming-lun; Kuo, Hsing-tao; Huang, Ching-i; Huang, Chung-feng; Hsieh, Ming-yen; Liang, Po-cheng; Lin, I-hung; Hsieh, Meng-hsuan; Lin, Zu-yau; Chen, Shinn-chern; Dai, Chia-yen; Huang, Jee-fu; Yu, Ming-lung; Chuang, Wan-long; | 書刊名 | The Kaohsiung Journal of Medical Sciences |
卷 期 | 37:2 2021.02[民110.02] |
頁 次 | 頁145-153 |
分類號 | 415.5362 |
關鍵詞 | Direct acting antivirals; Hepatitis C virus; Hepatocellular carcinoma; Sorafenib; Survival; |
語 文 | 英文(English) |